| Identification | Back Directory | [Name]
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline | [CAS]
196603-96-0 | [Synonyms]
4-(4-bromo-2-fluorophenylamino)-6-methoxyquinazolin-7-ol
4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline
4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-Quinazolinol
7-Quinazolinol, 4-[(4-broMo-2-fluorophenyl)aMino]-6-Methoxy-
6-Methoxy-7-hydroxy-4-(2''-fluoro-4''-broMoaniline)quinazoline
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline ISO 9001：2015 REACH | [EINECS(EC#)]
688-137-8 | [Molecular Formula]
C15H11BrFN3O2 | [MDL Number]
MFCD09955370 | [MOL File]
196603-96-0.mol | [Molecular Weight]
364.17 |
| Chemical Properties | Back Directory | [Melting point ]
268-270 °C | [Boiling point ]
471.0±45.0 °C(Predicted) | [density ]
1.663 | [storage temp. ]
Keep in dark place,Inert atmosphere,Room temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
5.51±0.40(Predicted) | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazolin is used in the synthesis of [18F]-(R)-FEPAQ, a potential PET imaging agent for VEGFR2. This would be helpful in the imaging of VEGFR in cance r patients.
|
|
|